 (>70% as
deﬁned by duplex ultrasound examination), was 11.1% at
2 years after CAS, signiﬁcantly higher than after CEA
(4.6%; P ¼ .001).465 In contrast, a secondary analysis of the
Carotid Revascularization Endarterectomy vs Stenting
Trial (CREST) trial showed no signiﬁcant difference in
restenosis or revascularization risk